US 9801894
Steroid compound for use in the treatment of hepatic encephalopathy
granted A61KA61K31/198A61K31/216
Quick answer
US patent 9801894 (Steroid compound for use in the treatment of hepatic encephalopathy) held by Umecrine Cognition AB expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Umecrine Cognition AB
- Grant date
- Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/198, A61K31/216, A61K31/437, A61K31/4375